Knee Osteoarthrosis
7
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Patients' Experiences of Information After Total Knee Arthroplasty - A Qualitative Interview Study
Use of Extracellular Vesicles (EV) for Knee Osteoarthrosis
Conservative Management vs. Arthroplasty in Knee Osteoarthritis
Participants With Knee Osteoarthrosis
Use of Wharton Jelly Derived Mesenchymal Stem Cells for Knee Osteoarthrosis
Use of Adipose Tissue Derived Mesenchymal Stem Cells for Knee Osteoarthrosis
Treatment of Knee Arthrosis With Platelet-derived Growth Factors vs. Hyaluronic Acid.